Company Overview and News
Stop missing out on important events!
The medical device tax suspension up to Jan 1, 2020, is one of the very few amendments that have garnered the maximum number of bipartisan votes in the House. (35-0)
On March 13, 2018, Dentsply Sirona (XRAY) closed trading at a price of $57.80 per share. The company registered its 52-week high of $68.98 on November 28, 2017, while a 52-week low of $52.54 was reported on August 21, 2017. (34-0)
Document UNITED STATES SECURITIES
Dentsply Sirona (XRAY) is one of the leading dental technology, equipment, and consumables providers in the United States. But the company has been going through some tough times following the merger of Sirona Dental Systems and Dentsply International and the subsequent formation of Dentsply Sirona in February 2016. (35-0)
Management has comparatively reasonable valuation expectations and the firm is preparing to enter Phase 3 trials for its lead candidate.
Mumbai: On the eve of International Women’s day, the Indian Dental Association conducted dental check up and a programme on oral health for women police. Girish Mahajan, Minister of Medical Education while launching the programme said, “I would request the IDA to lay more emphasis on the oral health of women in the rural areas. The health services for women in the rural areas are still neglected and need to be given priority. (10-0)
Henry Schein, Inc.’s (HSIC - Free Report) latest deal with Grifols (GRFS - Free Report) adds stimulus to its distribution business. Both companies have signed a distribution agreement, enabling the former to market and distribute the latter's 500mL Normal Saline solution (0.9% Sodium Chloride Injection, USP) in U.S. market. (15-0)
Third Point’s form 13F filed on February 14th highlights recent stocks purchases including Alphabet Inc Class A (Nasdaq: GOOGL), Intercontinental Exchange Inc (NYSE: ICE), and Netflix, Inc. (Nasdaq: NFLX). (69-0)
DENTSPLY SIRONA, Inc. (NASDAQ:XRAY) Q4 2017 Results Earnings Conference Call March 2, 2018 8:30 AM ET (5-0)
Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
Align Technology (ALGN) is a high-growth leading player in the orthodontics market, headquartered in San Jose, California. It develops clear aligners called Invisalign and 3D (three-dimensional) digital scanners. The company’s clear aligners have witnessed rapid growth in recent years, driven by strong market demand from customers who are shifting from metal braces to clear aligners. The company announced its fiscal 4Q17 and fiscal 2017 earnings on January 30, 2018. (39-0)
On February 23, 2018, Align Technology (ALGN) closed trading at $265.07. The stock fell ~3% after it reported its 52-week high of $287.32 on January 26, 2018. The stock registered a 52-week low of $100.57 about a year ago on February 24, 2017. (39-0)